Patient Blood Management Market : Global Industry analysis, Growth, Share, Segmentation and Forecast (2023–2029)


Patient Blood Management Market is expected to reach US$ 17.65 Bn. at a CAGR of 5.7% during the forecast period 2029.

Global Patient Blood Management Market Overview:

Patient Blood Management (PBM), a multidisciplinary approach adopted to limit the use of blood transfusion, minimizing blood loss at the time of surgical operations and optimizing the blood of the patient in all at-risk patients with the aim of improving their clinical outcomes. This is carried out by doctors for patients that possess the risk of blood loss at the time of surgical intervention. PBM has three main objectives:

Patient Blood Management MarketTo know about the Research Methodology :- Request Free Sample Report

1) Improving red cell mass, including treatments such as erythropoiesis-stimulating agents and iron and vitamin supplements.

2) Minimizing blood loss, by optimizing surgical and anesthetic techniques, treatment with tranexamic acid (TXA) and autologous blood salvage.

3) Harnessing and optimizing the tolerance of anaemia by promoting maximum pulmonary and cardiac function and the use of a restrictive transfusion threshold.

The report covers the detailed analysis of global Patient Blood Management System industry with the classifications of the market based on product, component and end-users. Analysis of past market dynamics from 2017 to 2021 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it.

The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Patient Blood Management Market Dynamics:

Rising demand for blood donation due to growing number of road accidents, trauma cases, increasing number of surgical procedures and rising prevalence of target diseases are the major factors contributing to the growth of market. Improved patient outcomes, faster recoveries and shorter stays in hospital, reduced patient exposure to the potential risks from receiving blood from another person also drive the market growth. The Patient blood Management has also shown benefits in the field of obstetrics for the treatment of anaemia, which occurs frequently during pregnancy, is mandatoryin order to improve maternal and foetal outcomes.
Also, rising awareness about the blood transfusion safety and adoption of patient blood management systems in developing economies is expected to provide a better growth opportunity in forecast period. According to the National Health Commission (NHC), the number of voluntary blood donations increasing from 328,000 in 1998 to 14.59 million in 2021.However, the high cost of the automated systems is likely to hamper the global market growth.

Global Patient Blood Management Market Regional Insights:

North America is expected to witness the lucrative market growth of xx% throughout the forecast period.

In terms of revenue, North America is expected to hold prominent share of patient blood management market followed by Europe during forecast period. Thanks to the increasing number of surgical procedures and rising incidences of target diseases like cancer, which requires the blood and blood products transfusion to make up the blood loss incurred during the procedures. Moreover, the presence of a large number of hospitals in the US is likely to support market growth. The US has over 7,200 active hospitals and a well-established healthcare sector.

In Europe, the market is driven by factors like well-established medical infrastructures and high number of road accidents where blood transfusion becomes the basic need. According to the Federal Statistical Office of Germany, the number of people injured in road accidents grew by 1.8% from November 2021 to November 2021. Along with this, surge in the preoperative anaemia has become a common factor in patients undergoing orthopedic and other major surgeries rises the demand for Patient Blood management in the region.However, there is a need for European healthcare providers to integrate PBM strategies into routine care for patients undergoing orthopaedic and other types of surgery in order to reduce the use of unnecessary transfusions and improve the quality of care.

Asia-Pacific is anticipated to grow at faster rate of xx%, owing to its rapidly developing healthcare sector, increasing patient pool and favorable government reimbursement policies.

Global Patient Blood Management Market Segment Analysis:

Based on the product type, the segment is further divided into instruments, accessories, reagents & kits and Software. According to the analysis, the instruments share is expected to dominate the market by registering a CAGR of xx% during forecast period.Thanks to increasing technological advancements, new product launches, increasing use of auto transfusion systemsduring surgeries and organ transplantation. It is further sub-segmented into blood processing, transfusion, diagnostics and storage devices.

Based on the component segment, the whole blood segment is anticipated to command the global market by xx%, due to increasing number of blood donor and donations worldwide. Also, rising prevalence of anaemia and blood cancer, which requires whole-blood unit and RBCs for transfusion will further propel the market growth.

Scope of the Global Patient Blood Management Market : Inquire before buying






Global Patient Blood Management Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 11.97 Bn.




Forecast Period 2023 to 2029 CAGR:
5.7%
Market Size in 2029:
US $ 17.65 Bn.




 Segments Covered:
by Product
Instruments
Blood processing devices
Blood transfusion devices
Blood culture screening devices
Diagnostic & testing instruments
Blood storage devices
Accessories
Reagents & Kits
Software




by Component
Whole Blood
Plasma




by End-Users
Blood banks
Hospitals
Diagnostics & Pathology labs






Patient Blood Management Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players operating in Global Patient Blood Management Market:

1.Haemonetics Corporation
2.Fresenius Se & Co. KGaA
3.Terumo Corporation
4.Immucor, Inc.
5.B. Braun Melsungen AG
6.Macopharma
7.Biomérieux SA
8.Asahi Kasei Medical Co. Ltd.
9.Kaneka Corporation
10.Bio-Rad Laboratories, Inc.
11.Abbott Laboratories
12.Grifols, S.A.
13.F. Hoffmann-La Roche LTD.
14.Livanova PLC
15.Danaher Corporation
16.Haier Biomedical
17.BAG Diagnostics GmbH

The report also helps in understanding Global Patient Blood Management System Market dynamics, structure by analyzing the market segments and project the Global Patient Blood Management System Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Patient Blood Management System Market make the report investor’s guide.

Frequently Asked Questions:

1. Which region has the largest share in Global Patient Blood Management Market?
Ans: North America region holds the highest share in 2022.

2. What is the growth rate of Global Patient Blood Management Market?
Ans: The Global Patient Blood Management Market is growing at a CAGR of 5.7% during forecasting period 2023-2029.

3. What is scope of the Global Patient Blood Management market report?
Ans: Global Patient Blood Management Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Patient Blood Management market?
Ans: The important key players in the Global Patient Blood Management Market are – Haemonetics Corporation, Fresenius Se & Co. KGaA, Terumo Corporation, Immucor, Inc., B. Braun Melsungen AG, Macopharma, Biomérieux SA, Asahi Kasei Medical Co. Ltd., Kaneka Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Grifols, S.A., F. Hoffmann-La Roche LTD., Livanova PLC, Danaher Corporation, Haier Biomedical, and BAG Diagnostics GmbH

5. What is the study period of this market?
Ans: The Global Patient Blood Management Market is studied from 2022 to 2029. 





Global Patient Blood Management Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: PATIENT BLOOD MANAGEMENT Market Size, By Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast
6.1. PATIENT BLOOD MANAGEMENT Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast, By Product
7.1. Introduction and Definition
7.2. Key Findings
7.3. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product
7.4. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By Product
7.5. PATIENT BLOOD MANAGEMENT Market Analysis, By Product
7.6. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By Product

8. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast, By Component
8.1. Introduction and Definition
8.2. Key Findings
8.3. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component
8.4. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By Component
8.5. PATIENT BLOOD MANAGEMENT Market Analysis, By Component
8.6. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By Component

9. Global PATIENT BLOOD MANAGEMENT Market Analysis and Forecast By End-Users
9.1. Introduction and Definition
9.2. Key Findings
9.3. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users
9.4. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By End-Users
9.5. PATIENT BLOOD MANAGEMENT Market Analysis, By End-Users
9.6. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By End-Users

10. Global PATIENT BLOOD MANAGEMENT Market Analysis, By Region
10.1. PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Region
10.2. PATIENT BLOOD MANAGEMENT Market Size (US$ Mn) Forecast, By Region
10.3. PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis, By Region

11. North America PATIENT BLOOD MANAGEMENT Market Analysis
11.1. Key Findings
11.2. North America PATIENT BLOOD MANAGEMENT Market Overview
11.3. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product
11.4. North America PATIENT BLOOD MANAGEMENT Market Forecast, By Product
11.4.1. Instruments
11.4.2. Accessories
11.4.3. Reagents & Kits
11.4.4. Software
11.5. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component
11.6. North America PATIENT BLOOD MANAGEMENT Market Forecast, By Component
11.6.1. Whole Blood
11.6.2. Plasma
11.7. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users
11.8. North America PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
11.8.1. Blood banks
11.8.2. Hospitals
11.8.3. Diagnostics & Pathology labs
11.9. North America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country
11.10. North America PATIENT BLOOD MANAGEMENT Market Forecast, By Country
11.10.1. U.S.
11.10.2. Canada
11.10.3. Mexico
11.11. North America PATIENT BLOOD MANAGEMENT Market Analysis, By Country
11.12. U.S. PATIENT BLOOD MANAGEMENT Market Forecast, By Product
11.12.1. Instruments
11.12.2. Accessories
11.12.3. Reagents & Kits
11.12.4. Software
11.13. U.S. PATIENT BLOOD MANAGEMENT Market Forecast, By Component
11.13.1. Whole Blood
11.13.2. Plasma
11.14. U.S. PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
11.14.1. Blood banks
11.14.2. Hospitals
11.14.3. Diagnostics & Pathology labs
11.15. Canada PATIENT BLOOD MANAGEMENT Market Forecast, By Product
11.15.1. Instruments
11.15.2. Accessories
11.15.3. Reagents & Kits
11.15.4. Software
11.16. Canada PATIENT BLOOD MANAGEMENT Market Forecast, By Component
11.16.1. Whole Blood
11.16.2. Plasma
11.17. Canada PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
11.17.1. Blood banks
11.17.2. Hospitals
11.17.3. Diagnostics & Pathology labs
11.18. Mexico PATIENT BLOOD MANAGEMENT Market Forecast, By Product
11.18.1. Instruments
11.18.2. Accessories
11.18.3. Reagents & Kits
11.18.4. Software
11.19. Mexico PATIENT BLOOD MANAGEMENT Market Forecast, By Component
11.19.1. Whole Blood
11.19.2. Plasma
11.20. Mexico PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
11.20.1. Blood banks
11.20.2. Hospitals
11.20.3. Diagnostics & Pathology labs
11.21. North America PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis
11.21.1. By Product
11.21.2. By Component
11.21.3. By End-Users
11.22. PEST Analysis
11.23. Key Trends
11.24. Key Developments

12. Europe PATIENT BLOOD MANAGEMENT Market Analysis
12.1. Key Findings
12.2. Europe PATIENT BLOOD MANAGEMENT Market Overview
12.3. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product
12.4. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.4.1. Instruments
12.4.2. Accessories
12.4.3. Reagents & Kits
12.4.4. Software
12.5. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component
12.6. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.6.1. Whole Blood
12.6.2. Plasma
12.7. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users
12.8. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.8.1. Blood banks
12.8.2. Hospitals
12.8.3. Diagnostics & Pathology labs
12.9. Europe PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country
12.10. Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Sweden
12.10.7. CIS countries
12.10.8. Rest of Europe
12.11. Germany PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.11.1. Instruments
12.11.2. Accessories
12.11.3. Reagents & Kits
12.11.4. Software
12.12. Germany PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.12.1. Whole Blood
12.12.2. Plasma
12.13. Germany PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.13.1. Blood banks
12.13.2. Hospitals
12.13.3. Diagnostics & Pathology labs
12.14. U.K. PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.14.1. Instruments
12.14.2. Accessories
12.14.3. Reagents & Kits
12.14.4. Software
12.15. U.K. PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.15.1. Whole Blood
12.15.2. Plasma
12.16. U.K. PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.16.1. Blood banks
12.16.2. Hospitals
12.16.3. Diagnostics & Pathology labs
12.17. France PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.17.1. Instruments
12.17.2. Accessories
12.17.3. Reagents & Kits
12.17.4. Software
12.18. France PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.18.1. Whole Blood
12.18.2. Plasma
12.19. France PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.19.1. Blood banks
12.19.2. Hospitals
12.19.3. Diagnostics & Pathology labs
12.20. Italy PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.20.1. Instruments
12.20.2. Accessories
12.20.3. Reagents & Kits
12.20.4. Software
12.21. Italy PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.21.1. Whole Blood
12.21.2. Plasma
12.22. Italy PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.22.1. Blood banks
12.22.2. Hospitals
12.22.3. Diagnostics & Pathology labs
12.23. Spain PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.23.1. Instruments
12.23.2. Accessories
12.23.3. Reagents & Kits
12.23.4. Software
12.24. Spain PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.24.1. Whole Blood
12.24.2. Plasma
12.25. Spain PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.25.1. Blood banks
12.25.2. Hospitals
12.25.3. Diagnostics & Pathology labs
12.26. Sweden PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.26.1. Instruments
12.26.2. Accessories
12.26.3. Reagents & Kits
12.26.4. Software
12.27. Sweden PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.27.1. Whole Blood
12.27.2. Plasma
12.28. Sweden PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.28.1. Blood banks
12.28.2. Hospitals
12.28.3. Diagnostics & Pathology labs
12.29. CIS countries PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.29.1. Instruments
12.29.2. Accessories
12.29.3. Reagents & Kits
12.29.4. Software
12.30. CIS countries PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.30.1. Whole Blood
12.30.2. Plasma
12.31. CIS countries PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.31.1. Blood banks
12.31.2. Hospitals
12.31.3. Diagnostics & Pathology labs
12.32. Rest of Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Product
12.32.1. Instruments
12.32.2. Accessories
12.32.3. Reagents & Kits
12.32.4. Software
12.33. Rest of Europe PATIENT BLOOD MANAGEMENT Market Forecast, By Component
12.33.1. Whole Blood
12.33.2. Plasma
12.34. Rest of Europe PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
12.34.1. Blood banks
12.34.2. Hospitals
12.34.3. Diagnostics & Pathology labs
12.35. Europe PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis
12.35.1. By Component
12.35.2. By Product
12.35.3. By End-Users
12.36. PEST Analysis
12.37. Key Trends
12.38. Key Developments

13. Asia Pacific PATIENT BLOOD MANAGEMENT Market Analysis
13.1. Key Findings
13.2. Asia Pacific PATIENT BLOOD MANAGEMENT Market Overview
13.3. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product
13.4. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.4.1. Instruments
13.4.2. Accessories
13.4.3. Reagents & Kits
13.4.4. Software
13.5. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component
13.6. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.6.1. Whole Blood
13.6.2. Plasma
13.7. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users
13.8. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.8.1. Blood banks
13.8.2. Hospitals
13.8.3. Diagnostics & Pathology labs
13.9. Asia Pacific PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country
13.10. Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. South Korea
13.10.5. Australia
13.10.6. ASEAN
13.10.7. Rest of Asia Pacific
13.11. Asia Pacific PATIENT BLOOD MANAGEMENT Market Analysis, By Country
13.12. China PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.12.1. Instruments
13.12.2. Accessories
13.12.3. Reagents & Kits
13.12.4. Software
13.13. China PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.13.1. Whole Blood
13.13.2. Plasma
13.14. China PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.14.1. Blood banks
13.14.2. Hospitals
13.14.3. Diagnostics & Pathology labs
13.15. India PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.15.1. Instruments
13.15.2. Accessories
13.15.3. Reagents & Kits
13.15.4. Software
13.16. India PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.16.1. Whole Blood
13.16.2. Plasma
13.17. India PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.17.1. Blood banks
13.17.2. Hospitals
13.17.3. Diagnostics & Pathology labs
13.18. Japan PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.18.1. Instruments
13.18.2. Accessories
13.18.3. Reagents & Kits
13.18.4. Software
13.19. Japan PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.19.1. Whole Blood
13.19.2. Plasma
13.20. Japan PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.20.1. Blood banks
13.20.2. Hospitals
13.20.3. Diagnostics & Pathology labs
13.21. South Korea PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.21.1. Instruments
13.21.2. Accessories
13.21.3. Reagents & Kits
13.21.4. Software
13.22. South Korea PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.22.1. Whole Blood
13.22.2. Plasma
13.23. South Korea PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.23.1. Blood banks
13.23.2. Hospitals
13.23.3. Diagnostics & Pathology labs
13.24. Australia PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.24.1. Instruments
13.24.2. Accessories
13.24.3. Reagents & Kits
13.24.4. Software
13.25. Australia PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.25.1. Whole Blood
13.25.2. Plasma
13.26. Australia PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.26.1. Blood banks
13.26.2. Hospitals
13.26.3. Diagnostics & Pathology labs
13.27. ASEAN PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.27.1. Instruments
13.27.2. Accessories
13.27.3. Reagents & Kits
13.27.4. Software
13.28. ASEAN PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.28.1. Whole Blood
13.28.2. Plasma
13.29. ASEAN PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.29.1. Blood banks
13.29.2. Hospitals
13.29.3. Diagnostics & Pathology labs
13.30. Rest of Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Product
13.30.1. Instruments
13.30.2. Accessories
13.30.3. Reagents & Kits
13.30.4. Software
13.31. Rest of Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By Component
13.31.1. Whole Blood
13.31.2. Plasma
13.32. Rest of Asia Pacific PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
13.32.1. Blood banks
13.32.2. Hospitals
13.32.3. Diagnostics & Pathology labs
13.33. Asia Pacific PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis
13.33.1. By Product
13.33.2. By Component
13.33.3. By End-Users
13.34. PEST Analysis
13.35. Key Trends
13.36. Key Developments

14. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Analysis
14.1. Key Findings
14.2. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Overview
14.3. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product
14.4. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Product
14.4.1. Instruments
14.4.2. Accessories
14.4.3. Reagents & Kits
14.4.4. Software
14.5. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component
14.6. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Component
14.6.1. Whole Blood
14.6.2. Plasma
14.7. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users
14.8. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
14.8.1. Blood banks
14.8.2. Hospitals
14.8.3. Diagnostics & Pathology labs
14.9. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country
14.10. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Country
14.10.1. GCC Countries
14.10.2. South Africa
14.10.3. Nigeria
14.10.4. Egypt
14.10.5. Rest of Middle East & Africa
14.11. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Analysis, By Country
14.12. GCC Countries PATIENT BLOOD MANAGEMENT Market Forecast, By Product
14.12.1. Instruments
14.12.2. Accessories
14.12.3. Reagents & Kits
14.12.4. Software
14.13. GCC Countries PATIENT BLOOD MANAGEMENT Market Forecast, By Component
14.13.1. Whole Blood
14.13.2. Plasma
14.14. GCC Countries PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
14.14.1. Blood banks
14.14.2. Hospitals
14.14.3. Diagnostics & Pathology labs
14.15. South Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Product
14.15.1. Instruments
14.15.2. Accessories
14.15.3. Reagents & Kits
14.15.4. Software
14.16. South Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Component
14.16.1. Whole Blood
14.16.2. Plasma
14.17. South Africa PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
14.17.1. Blood banks
14.17.2. Hospitals
14.17.3. Diagnostics & Pathology labs
14.18. Nigeria PATIENT BLOOD MANAGEMENT Market Forecast, By Product
14.18.1. Instruments
14.18.2. Accessories
14.18.3. Reagents & Kits
14.18.4. Software
14.19. Nigeria PATIENT BLOOD MANAGEMENT Market Forecast, By Component
14.19.1. Whole Blood
14.19.2. Plasma
14.20. Nigeria PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
14.20.1. Blood banks
14.20.2. Hospitals
14.20.3. Diagnostics & Pathology labs
14.21. Egypt PATIENT BLOOD MANAGEMENT Market Forecast, By Product
14.21.1. Instruments
14.21.2. Accessories
14.21.3. Reagents & Kits
14.21.4. Software
14.22. Egypt PATIENT BLOOD MANAGEMENT Market Forecast, By Component
14.22.1. Whole Blood
14.22.2. Plasma
14.23. Egypt PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
14.23.1. Blood banks
14.23.2. Hospitals
14.23.3. Diagnostics & Pathology labs
14.24. Rest of Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Product
14.24.1. Instruments
14.24.2. Accessories
14.24.3. Reagents & Kits
14.24.4. Software
14.25. Rest of Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By Component
14.25.1. Whole Blood
14.25.2. Plasma
14.26. Rest of Middle East & Africa PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
14.26.1. Blood banks
14.26.2. Hospitals
14.26.3. Diagnostics & Pathology labs
14.27. Middle East & Africa PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis
14.27.1. By Product
14.27.2. By Component
14.27.3. By End-Users
14.28. PEST Analysis
14.29. Key Trends
14.30. Key Developments

15. South America PATIENT BLOOD MANAGEMENT Market Analysis
15.1. Key Findings
15.2. South America PATIENT BLOOD MANAGEMENT Market Overview
15.3. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Product
15.4. South America PATIENT BLOOD MANAGEMENT Market Forecast, By Product
15.4.1. Instruments
15.4.2. Accessories
15.4.3. Reagents & Kits
15.4.4. Software
15.5. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Component
15.6. South America PATIENT BLOOD MANAGEMENT Market Forecast, By Component
15.6.1. Whole Blood
15.6.2. Plasma
15.7. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By End-Users
15.8. South America PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
15.8.1. Blood banks
15.8.2. Hospitals
15.8.3. Diagnostics & Pathology labs
15.9. South America PATIENT BLOOD MANAGEMENT Market Value Share Analysis, By Country
15.10. South America PATIENT BLOOD MANAGEMENT Market Forecast, By Country
15.10.1. Brazil
15.10.2. Colombia
15.10.3. Argentina
15.10.4. Rest of South America
15.11. South America PATIENT BLOOD MANAGEMENT Market Analysis, By Country
15.12. Brazil PATIENT BLOOD MANAGEMENT Market Forecast, By Product
15.12.1. Instruments
15.12.2. Accessories
15.12.3. Reagents & Kits
15.12.4. Software
15.13. Brazil PATIENT BLOOD MANAGEMENT Market Forecast, By Component
15.13.1. Whole Blood
15.13.2. Plasma
15.14. Brazil PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
15.14.1. Blood banks
15.14.2. Hospitals
15.14.3. Diagnostics & Pathology labs
15.15. Colombia PATIENT BLOOD MANAGEMENT Market Forecast, By Product
15.15.1. Instruments
15.15.2. Accessories
15.15.3. Reagents & Kits
15.15.4. Software
15.16. Colombia PATIENT BLOOD MANAGEMENT Market Forecast, By Component
15.16.1. Whole Blood
15.16.2. Plasma
15.17. Colombia PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
15.17.1. Blood banks
15.17.2. Hospitals
15.17.3. Diagnostics & Pathology labs
15.18. Argentina PATIENT BLOOD MANAGEMENT Market Forecast, By Product
15.18.1. Instruments
15.18.2. Accessories
15.18.3. Reagents & Kits
15.18.4. Software
15.19. Argentina PATIENT BLOOD MANAGEMENT Market Forecast, By Component
15.19.1. Whole Blood
15.19.2. Plasma
15.20. Argentina PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
15.20.1. Blood banks
15.20.2. Hospitals
15.20.3. Diagnostics & Pathology labs
15.21. Rest of South America PATIENT BLOOD MANAGEMENT Market Forecast, By Product
15.21.1. Instruments
15.21.2. Accessories
15.21.3. Reagents & Kits
15.21.4. Software
15.22. Rest of South America PATIENT BLOOD MANAGEMENT Market Forecast, By Component
15.22.1. Whole Blood
15.22.2. Plasma
15.23. Rest of South America PATIENT BLOOD MANAGEMENT Market Forecast, By End-Users
15.23.1. Blood banks
15.23.2. Hospitals
15.23.3. Diagnostics & Pathology labs
15.24. South America PATIENT BLOOD MANAGEMENT Market Attractiveness Analysis
15.24.1. By Product
15.24.2. By Component
15.24.3. By End-Users
15.25. PEST Analysis
15.26. Key Trends
15.27. Key Developments

16. Company Profiles
16.1. Market Share Analysis, By Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players By price, presence, market share, Component, and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A By Regions, Investment and Component
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. Haemonetics Corporation
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. Fresenius Se & Co. KGaA
16.3.3. Terumo Corporation
16.3.4. Immucor, Inc.
16.3.5. B. Braun Melsungen AG
16.3.6. Macopharma
16.3.7. Biomérieux SA
16.3.8. Asahi Kasei Medical Co. Ltd.
16.3.9. Kaneka Corporation
16.3.10. Bio-Rad Laboratories, Inc.
16.3.11. Abbott Laboratories
16.3.12. Grifols, S.A.
16.3.13. F. Hoffmann-La Roche LTD.
16.3.14. Livanova PLC
16.3.15. Danaher Corporation
16.3.16. Haier Biomedical
16.3.17. BAG Diagnostics GmbH

17. Primary key Insights
  • INQUIRE BEFORE BUYING